LY3454738

LY3454738 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY3454738, covering 2022-03-11 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]